Can ochratoxin A and enniatin B1 retention after water-damaged building exposure contribute to fatigue, pain, and cognitive symptoms?

Exposure to water-damaged buildings can lead to the internal retention of mycotoxins, notably Ochratoxin A (OTA) and Enniatin B1 (ENN B1). This toxic accumulation triggers a cascade of cellular dysfunction that underlies chronic, multi-system symptoms.

Clinical evidence

• Symptom Association: Internal retention of OTA, demonstrated by elevated urinary excretion in exposed individuals, is clinically associated with chronic fatigue, musculoskeletal pain, headaches, and cognitive deficits ("brain fog"). In clinical cohorts, OTA has been detected in up to 83% of patients with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS). The specific clinical footprint of ENN B1 in these syndromes remains an emerging area of research.

Mechanistic explanations

• Mitochondrial Toxicity: Both toxins directly compromise cellular energy production. OTA uncouples oxidative phosphorylation and directly inhibits respiratory complex II (succinate dehydrogenase). ENN B1 acts as a potassium ionophore, collapsing the mitochondrial membrane potential ($\Delta\Psi_m$) and opening the mitochondrial permeability transition pore (mPTP). These combined actions severely deplete cellular ATP.
• Oxidative and Inflammatory Cascades: OTA drives systemic inflammation by inhibiting the Nrf2 antioxidant pathway and activating NF-kB, which upregulates inflammatory cytokines like TNF-α, IL-1β, and IL-6. Concurrently, ENN B1-induced reactive oxygen species (ROS) accumulation triggers lipid peroxidation and further drives mitochondrial structural collapse.

Bottom line

• Retention of Ochratoxin A from water-damaged environments is clinically and mechanistically linked to chronic fatigue, pain, and cognitive symptoms through mitochondrial energetic failure and systemic inflammation, while Enniatin B1 serves as a plausible, emerging co-factor in mitochondrial stress.